Pulse Biosciences Inc.

NASDAQ: PLSE · Real-Time Price · USD
17.37
0.06 (0.35%)
At close: Aug 15, 2025, 10:18 AM

Pulse Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 700K 1.42M
Cost of Revenue
1.18M 1.21M 11.94M 1.97M
Gross Profit
-1.18M -1.21M -11.24M -550K
Operating Income
-54.36M -43.57M -58.06M -63.01M
Interest Income
2.67M 2.46M 263K 646K
Pretax Income
-53.59M -42.21M -58.51M -63.66M
Net Income
-53.59M -42.21M -58.51M -63.66M
Selling & General & Admin
23.92M 15.78M 25.97M 33.82M
Research & Development
32.34M 27.8M 20.84M 28.64M
Other Expenses
n/a -1.21M n/a n/a
Operating Expenses
56.26M 42.37M 46.81M 62.46M
Interest Expense
n/a 1.1M 448K 646K
Selling & Marketing Expenses
n/a n/a 12.02M 14.75M
Cost & Expenses
56.26M 43.57M 58.76M 64.43M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
58.4M 48.04M 33.94M 27.96M
Shares Outstanding (Diluted)
58.4M 48.04M 33.94M 27.96M
EPS (Basic)
-0.92 -0.88 -1.72 -2.28
EPS (Diluted)
-0.92 -0.88 -1.72 -2.28
EBITDA
-52.41M -42.37M -56.7M -61.87M
EBIT
-53.59M -43.57M -58.06M -63.01M
Depreciation & Amortization
1.18M 1.21M 1.35M 1.15M